Verrica Pharmaceuticals Inc. (VRCA)
Data as of , from SEC Form 4 filings.
Net insider buying (90d)Watch VRCA
See up to 3 months of VRCA. The 7-day demo opens the 1M and 3M ranges and puts VRCA on your watchlist.
Start 7-day demoLatest VRCA insider trades
About Verrica Pharmaceuticals Inc. (VRCA)
Verrica Pharmaceuticals Inc. files with the SEC under CIK 0001660334 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
VRCA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 6 | 42,230 | $211K |
VRCA insider transactions (Form 4)
4524 Form 4 filings on record, the earliest from Oct 11, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David Zawitz - Officer | Open-market purchase | Common Stock | 6,000 | $4.98 footnote F1 | $30K | |
| ||||||
| Noah L. Rosenberg - Officer | Open-market purchase | Common Stock | 4,200 | $4.91 footnote F1 | $21K | |
| Noah L. Rosenberg - Officer | Open-market purchase | Common Stock | 2,030 | $4.92 footnote F1 | $10K | |
| ||||||
| Jayson Rieger - Officer | Open-market purchase | Common Stock | 20,000 | $5.06 footnote F1 | $101K | |
| Jayson Rieger - Officer | Open-market purchase | Common Stock | 5,000 | $4.91 | $25K | |
| ||||||
| John J. Kirby - Officer | Open-market purchase | Common Stock | 5,000 | $4.93 footnote F1 | $25K | |
| ||||||
 Lawrence Eichenfield | Grant or award | Stock Option (right to buy) | 16,000 | $0.00 | - | |
| Diem Nguyen | Grant or award | Stock Option (right to buy) | 16,000 | $0.00 | - | |
| Mark A. Prygocki Sr. | Grant or award | Stock Option (right to buy) | 16,000 | $0.00 | - | |
| Noah L. Rosenberg - Officer | Grant or award | Employee Stock Option (right to buy) | 233,840 | $0.00 | - | |
| David Zawitz - Officer | Grant or award | Employee Stock Option (right to buy) | 171,340 | $0.00 | - | |
| Jayson Rieger - Officer | Grant or award | Employee Stock Option (right to buy) | 512,269 | $0.00 | - | |
| Gavin Corcoran | Grant or award | Stock Option (right to buy) | 16,000 | $0.00 | - | |
| David Zawitz - Officer | Open-market purchase | Common Stock | 10,000 | $4.24 | $42K | |
| David Zawitz - Officer | Open-market purchase | Series C Warrant (right to buy) | 2,500 | - footnote F3 | - | |
| ||||||
| Jayson Rieger - Officer | Open-market purchase | Common Stock | 94,311 | $4.24 | $400K | |
| Jayson Rieger - Officer | Open-market purchase | Series C Warrant (right to buy) | 23,577 | - footnote F4 | - | |
| ||||||
| Noah L. Rosenberg - Officer | Open-market purchase | Common Stock | 2,357 | $4.24 | $10K | |
| Noah L. Rosenberg - Officer | Open-market purchase | Series C Warrant (right to buy) | 589 | - footnote F2 | - | |
| ||||||
| John J. Kirby - Officer | Open-market purchase | Common Stock | 3,536 | $4.24 | $15K | |
| John J. Kirby - Officer | Open-market purchase | Series C Warrant (right to buy) | 884 | - footnote F3 | - | |
| ||||||
 Paul B. Manning | Open-market purchase | Common Stock | 1,375,380 | $4.24 | $5.84M | |
| Paul B. Manning | Open-market purchase | Common Stock | 2,750,762 | $4.24 | $11.67M | |
| Paul B. Manning | Open-market purchase | Series C Warrant (right to buy) | 343,845 | - footnote F8 | - | |
| Paul B. Manning | Open-market purchase | Series C Warrant (right to buy) | 687,690 | - footnote F9 | - | |
| ||||||
| Mark A. Prygocki Sr. | Grant or award | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| David Zawitz - Officer | Grant or award | Employee Stock Option (right to buy) | 950,000 | $0.00 | - | |
| Jayson Rieger - Officer | Open-market purchase | Common Stock | 280,898 | - | - | |
| Jayson Rieger - Officer | Gift | Common Stock | 50,000 | $0.00 | - | |
| Jayson Rieger - Officer | Open-market purchase | Series A Warrants (right to buy) | 140,449 | - | - | |
| Jayson Rieger - Officer | Open-market purchase | Series B Warrants (right to buy) | 140,449 | - | - | |
| John A. Stalfort III | Open-market purchase | Common Stock | 1,123,595 | - | - | |
| John A. Stalfort III | Gift | Common Stock | 50,000 | $0.00 | - | |
| John A. Stalfort III | Open-market purchase | Series A Warrants (right to buy) | 561,797 | - | - | |
| John A. Stalfort III | Open-market purchase | Series B Warrants (right to buy) | 561,797 | - | - | |
| Paul B. Manning | Open-market purchase | Common Stock | 18,426,966 | - | - | |
| Paul B. Manning | Open-market purchase | Common Stock | 4,494,382 | - | - | |
| Paul B. Manning | Gift | Common Stock | 450,000 | $0.00 | - | |
| Paul B. Manning | Open-market purchase | Series A Warrants (right to buy) | 9,213,483 | - | - | |
| Paul B. Manning | Open-market purchase | Series B Warrants (right to buy) | 9,213,483 | - | - | |
| Paul B. Manning | Open-market purchase | Series A Warrants (right to buy) | 2,247,191 | - | - | |
| Paul B. Manning | Open-market purchase | Series B Warrants (right to buy) | 2,247,191 | - | - | |
| Jayson Rieger - Officer | Grant or award | Employee Stock Option (right to buy) | 2,000,000 | $0.00 | - | |
| John J. Kirby - Officer | Grant or award | Common Stock | 54,267 | $0.00 | - | |
| Christopher G. Hayes - Officer | Grant or award | Employee Stock Option (right to buy) | 50,000 | $0.00 | - | |
Item 2.02, 9.01
Item 5.02, 5.07, 9.01
Item 2.02, 9.01
Item 2.02, 9.01
VRCA insider trading FAQ
What is the latest insider trade for VRCA?
Verrica Pharmaceuticals Inc. (VRCA) had 4 insider filings in the last 90 days, with the most recent on 2026-08-18. The full record for VRCA runs to 24 Form 4 filings, the earliest from 2024-10-11. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying VRCA stock?
6 insider purchases of VRCA were filed in the last 90 days, totaling $211K.
How many insiders are selling VRCA stock?
No insider sales of VRCA were filed in the last 90 days.
Where can I see VRCA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects VRCA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - David Zawitz view on EDGAR
- - Noah L. Rosenberg view on EDGAR
- - Jayson Rieger view on EDGAR
- - John J. Kirby view on EDGAR
- - Lawrence Eichenfield view on EDGAR
- - Diem Nguyen view on EDGAR
- - Mark A. Prygocki Sr. view on EDGAR
- - Noah L. Rosenberg view on EDGAR
- - David Zawitz view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where VRCA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow VRCA with a 7-day demo
- VRCA on your watchlist
- Every VRCA Form 4 filing on record
- Up to 3 months of VRCA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
